ArticleTranslational cancer research2025
Determining the optimal surgical margin using whole scene pathology and molecular surgical margin analysis in colorectal cancer radical surgery-a cross-sectional study.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: An inadequate surgical margin is the major reason for disease recurrence; however, tumor recurrence sometimes even occurs in patients with pathologically negative surgical margins. The aim of this study is to determine the ideal surgical margin in radical colorectal cancer (CRC) surgery using panoramic pathology coupled with a molecular surgical margin (MSM) analysis. Methods: The surgical specimens and clinical data of 194 CRC patients at the Guangxi Medical University Cancer Hospital from January 2016 to December 2019 were collected. Specifically, whole pathological sections of intact primary lesions of CRC were collected. Carcinoembryonic antigen (CEA) and methylation detection were used to analyze the molecular changes and protein expression patterns of different regions. Results: A total of 194 patients with high-quality sections and complete clinical data were included in this study. Different tumor cells and different regions of the primary focus of CRC had different protein expression patterns, and some cells expressed multiple proteins. The submucosal interstitial space of the tumor margin (i.e., the extension area) and the submucosal space near the cancer area was obvious. The positive rate of CEA in the normal mucosal tissues of distant cancer was 19.15%. Conclusions: A tumor is a disease caused by molecular regulation failure and internal environment disorder at the high molecular level of the body. "Cell-cell" interactions may play an important role. In tumor surgery, the cutting edge may not always need to be as extensive as possible, especially when function preservation is important, which affects the quality of life of patients and ultimately affects the actual treatment outcomes. Further high-powered randomized trials need to be conducted to confirm the results of this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.